Product
Placebo FP-025
1 clinical trial
2 indications
Indication
AsthmaIndication
Chronic Obstructive Pulmonary DiseaseClinical trial
The Effect of FP-025, a MMP-12 Inhibitor, on Allergen-induced Airway Responses, Airway Inflammation and Aspects of Airway Remodeling in Subjects With Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma (HDM)-Allergic AsthmaStatus: Completed, Estimated PCD: 2022-12-30